1.Jacob SW, Herschler R: Pharmacology of DMSO. Cryobiology 1986, 23(1):14–27.
2.Chambers I, Smith A: Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 2004, 23(43):7150–7160.
3.Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH: A protein interaction network for pluripotency of embryonic stem cells. Nature 2006, 444(7117):364–368.
4.Chen X, Xu B, Han X, Mao Z, Talbot P, Chen M, Du G, Chen A, Liu J, Wang X et al: Effect of bisphenol A on pluripotency of mouse embryonic stem cells and differentiation capacity in mouse embryoid bodies. Toxicol In Vitro, 27(8):2249–2255.
5.Moorthy PP, Kumar AA, Devaraj H: Expression of the Gas7 gene and Oct4 in embryonic stem cells of mice. Stem Cells Dev 2005, 14(6):664–670.
6.Vallier L, Pedersen RA: Human embryonic stem cells: an in vitro model to study mechanisms controlling pluripotency in early mammalian development. Stem Cell Rev 2005, 1(2):119–130.
7.Sroczynska P, Lancrin C, Pearson S, Kouskoff V, Lacaud G: In vitro differentiation of mouse embryonic stem cells as a model of early hematopoietic development. Methods Mol Biol 2009, 538:317–334.
8.Balmer NV, Weng MK, Zimmer B, Ivanova VN, Chambers SM, Nikolaeva E, Jagtap S, Sachinidis A, Hescheler J, Waldmann T et al: Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Hum Mol Genet, 21(18):4104–4114.
9.Youngblood BA, Alfano R, Pettit SC, Zhang D, Dallmann HG, Huang N, Macdonald CC: Application of recombinant human leukemia inhibitory factor (LIF) produced in rice (Oryza sativa L.) for maintenance of mouse embryonic stem cells. J Biotechnol, 172:67–72.
10.Ogawa K, Matsui H, Ohtsuka S, Niwa H: A novel mechanism for regulating clonal propagation of mouse ES cells. Genes Cells 2004, 9(5):471–477.
11.Kawahara Y, Manabe T, Matsumoto M, Kajiume T, Yuge L: LIF-free embryonic stem cell culture in simulated microgravity. PLoS One 2009, 4(7):e6343.
12.Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16(1):6–21.
13.Smith ZD, Chan MM, Mikkelsen TS, Gu H, Gnirke A, Regev A, Meissner A: A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature, 484(7394):339–344.
14.Seisenberger S, Andrews S, Krueger F, Arand J, Walter J, Santos F, Popp C, Thienpont B, Dean W, Reik W: The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells. Mol Cell, 48(6):849–862.
15.Gu TP, Guo F, Yang H, Wu HP, Xu GF, Liu W, Xie ZG, Shi L, He X, Jin SG et al: The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature, 477(7366):606–610.
16.Yamaguchi S, Hong K, Liu R, Shen L, Inoue A, Diep D, Zhang K, Zhang Y: Tet1 controls meiosis by regulating meiotic gene expression. Nature, 492(7429):443–447.
17.Hackett JA, Sengupta R, Zylicz JJ, Murakami K, Lee C, Down TA, Surani MA: Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science, 339(6118):448–452.
18.Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L et al: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324(5929):930–935.
19.Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R, Ko M, McLoughlin EM, Brudno Y, Mahapatra S, Kapranov P et al: Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature, 473(7347):394–397.
20.Wu H, D’Alessio AC, Ito S, Xia K, Wang Z, Cui K, Zhao K, Sun YE, Zhang Y: Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature, 473(7347):389–393.
21.Williams K, Christensen J, Pedersen MT, Johansen JV, Cloos PA, Rappsilber J, Helin K: TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature, 473(7347):343–348.
22.Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA, Marques CJ, Andrews S, Reik W: Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature, 473(7347):398–402.
23.Hollebeeck S, Raas T, Piront N, Schneider YJ, Toussaint O, Larondelle Y, During A: Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco–2 cell model. Toxicol Lett, 206(3):268–275.
24.Pal R, Mamidi MK, Das AK, Bhonde R: Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation potential of human embryonic stem cells. Arch Toxicol, 86(4):651–661.
25.Thaler R, Spitzer S, Karlic H, Klaushofer K, Varga F: DMSO is a strong inducer of DNA hydroxymethylation in pre-osteoblastic MC3T3-E1 cells. Epigenetics, 7(6):635–651.
26.Singh MK, Singh KP, Kumar D, Shah RA, Anand T, Chauhan MS, Manik RS, Singla SK, Palta P: Buffalo (Bubalus bubalis) ES cell-like cells are capable of in vitro skeletal myogenic differentiation. Reprod Domest Anim, 48(2):284–291.
27.Friend C, Scher W, Holland JG, Sato T: Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci U S A 1971, 68(2):378–382.
28.Yoshizawa T, Watanabe S, Hirose M, Miyazaki A, Sato N: Dimethylsulfoxide maintains intercellular communication by preserving the gap junctional protein connexin32 in primary cultured hepatocyte doublets from rats. J Gastroenterol Hepatol 1997, 12(4):325–330.
29.Su T, Waxman DJ: Impact of dimethyl sulfoxide on expression of nuclear receptors and drug-inducible cytochromes P450 in primary rat hepatocytes. Arch Biochem Biophys 2004, 424(2):226–234.
30.Hay DC, Zhao D, Fletcher J, Hewitt ZA, McLean D, Urruticoechea-Uriguen A, Black JR, Elcombe C, Ross JA, Wolf R et al: Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells 2008, 26(4):894–902.
31.Iwatani M, Ikegami K, Kremenska Y, Hattori N, Tanaka S, Yagi S, Shiota K: Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body. Stem Cells 2006, 24(11):2549–2556.
32.Marks PA, Breslow R: Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 2007, 25(1):84–90.
33.Cheung WM, Ng WW, Kung AW: Dimethyl sulfoxide as an inducer of differentiation in preosteoblast MC3T3-E1 cells. FEBS Lett 2006, 580(1):121–126.
34.Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C, Schafer X, Lun Y, Lemischka IR: Dissecting self-renewal in stem cells with RNA interference. Nature 2006, 442(7102):533–538.
35.O’Connor MD, Kardel MD, Eaves CJ: Functional assays for human embryonic stem cell pluripotency. Methods Mol Biol, 690:67–80.
36.O’Connor MD, Kardel MD, Iosfina I, Youssef D, Lu M, Li MM, Vercauteren S, Nagy A, Eaves CJ: Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells 2008, 26(5):1109–1116.
37.Smith AG: Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 2001, 17:435–462.
38.Pera MF, Tam PP: Extrinsic regulation of pluripotent stem cells. Nature, 465(7299):713–720.
39.Nichols J, Smith A: The origin and identity of embryonic stem cells. Development, 138(1):3–8.
40.Jasmin, Spray DC, Campos de Carvalho AC, Mendez-Otero R: Chemical induction of cardiac differentiation in p19 embryonal carcinoma stem cells. Stem Cells Dev, 19(3):403–412.
41.Tay YM, Tam WL, Ang YS, Gaughwin PM, Yang H, Wang W, Liu R, George J, Ng HH, Perera RJ et al: MicroRNA–134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells 2008, 26(1):17–29.
42.Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I: MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455(7216):1124–1128.
43.Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, Stahl M, Rogers D: Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988, 336(6200):688–690.
44.Gearing DP, Gough NM, King JA, Hilton DJ, Nicola NA, Simpson RJ, Nice EC, Kelso A, Metcalf D: Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J 1987, 6(13):3995–4002.
45.Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM: Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988, 336(6200):684–687.
46.Ying QL, Smith AG: Defined conditions for neural commitment and differentiation. Methods Enzymol 2003, 365:327–341.
47.Niwa H: How is pluripotency determined and maintained? Development 2007, 134(4):635–646.
48.Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J et al: Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133(6):1106–1117.
49.Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct–3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000, 24(4):372–376.
50.Zhu G, Li Y, Zhu F, Wang T, Jin W, Mu W, Lin W, Tan W, Li W, Street RC et al: Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogramming. Stem Cell Reports, 2(3):253–261.
51.Rodrigues AS, Pereira SL, Correia M, Gomes A, Perestrelo T, Ramalho-Santos J: Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells. PLoS One, 10(8):e0135617.
52.Varum S, Momcilovic O, Castro C, Ben-Yehudah A, Ramalho-Santos J, Navara CS: Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain. Stem Cell Res 2009, 3(2–3):142–156.